Quiescent and activated mouse granulocytes do not express granzyme A and B or perforin: Similarities or differences with human polymorphonuclear leukocytes?

Blood

Volumn 106, Issue 8, 2005, Pages 2871-2878

  Martin, Praxedis ^b   Wallich, Reinhard ^b   Pardo, Julian ^b   Müllbacher, Arno ^b   Munder, Markus ^b   Modolell, Manuel ^b   Simon, Markus M ^a  

^a MAX PLANCK INSTITUTE OF IMMUNOBIOLOGY AND EPIGENETICS   (Germany)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

GRANZYME A; GRANZYME B; PERFORIN;

ANIMAL CELL; ARTICLE; CELL ACTIVATION; CELL POPULATION; CONTROLLED STUDY; CYTOLOGY; CYTOTOXIC T LYMPHOCYTE; ENZYME ANALYSIS; ENZYME SYNTHESIS; FEMALE; FLOW CYTOMETRY; GRANULOCYTE; HUMAN; HUMAN CELL; IMMUNIZATION; IMMUNOELECTRON MICROSCOPY; INFECTION; MALE; MOUSE; NATURAL KILLER CELL; NEUTROPHIL; NONHUMAN; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 27144526642     PISSN: 00064971     EISSN: 00064971     Source Type: Journal    
DOI: 10.1182/blood-2005-04-1522     Document Type: Article

References (39)

1. Kagi D, Ledermann B, Burki K, et al. Cytotoxicity mediated by T cells and natural killer cells is greatly impaired in perforin-deficient mice. Nature. 1994;369:31-37.
2. Lowin B, Hahne M, Mattmann C, Tschopp J. Cytolytic T-cell cytotoxicity is mediated through perforin and Fas lytic pathways. Nature. 1994;370:650-652.
3. Heusel JW, Wesselschmidt RL, Shresta S, Russell JH, Ley TJ. Cytotoxic lymphocytes require granzyme B for the rapid induction of DNA fragmentation and apoptosis in allogeneic target cells. Cell. 1994;76:977-987.
4. Simon MM, Hausmann M, Tran T, et al. In vitro-and ex vivo-derived cytolytic leukocytes from granzyme A x B double knockout mice are defective in granule-mediated apoptosis but not lysis of target cells. J Exp Med. 1997;186:1781-1786.
5. Balkow S, Kersten A, Tran TT, et al. Concerted action of the FasL/Fas and perforin/granzyme A and B pathways is mandatory for the development of early viral hepatitis but not for recovery from viral infection. J Virol. 2001;75:8781-8791.
6. Russell JH, Ley TJ. Lymphocyte-mediated cytotoxicity. Annu Rev Immunol. 2002;20:323-370.
7. Trapani JA, Sutton VR. Granzyme B: pro-apoptotic, antiviral and antitumor functions. Curr Opin Immunol. 2003;15:533-543.
8. Pardo J, Bosque A, Brehm R, et al. Apoptotic pathways are selectively activated by granzyme A and/or granzyme B in CTL-mediated target cell lysis. J Cell Biol. 2004;167:457-468.
9. Müllbacher A, Waring P, Hia RT, et al. Granzymes are the essential downstream effector molecules for the control of primary virus infections by cytolytic leukocytes. Proc Natl Acad Sci U S A. 1999;96:13950-13955.
10. Lieberman J, Fan Z. Nuclear war: the granzyme A-bomb. Curr Opin Immunol. 2003;15:553-559.
11. + lymphocytes. Eur J Immunol. 1987;17:1625-1633.
12. Simon HG, Fruth U, Eckerskorn C, et al. Induction of T cell serine proteinase 1 (TSP-1)-specific mRNA in mouse T lymphocytes. Eur J Immunol. 1988;18:855-861.
13. + T lymphocytes. Eur J Immunol. 1988;18:773-781.
14. Zheng LM, Ojcius DM, Liu CC, et al. Immunogold labeling of perforin and serine esterases in granulated metrial gland cells. FASEB J. 1991;5:79-85.
15. Garcia-Sanz JA, MacDonald HR, Jenne DE, Tschopp J, Nabholz M. Cell specificity of granzyme gene expression. J Immunol. 1990;145:3111-3118.
16. Sayers TJ, Brooks AD, Ward JM, et al. The restricted expression of granzyme M in human lymphocytes. J Immunol. 2001;166:765-771.
17. Sedelies KA, Sayers TJ, Edwards KM, et al. Discordant regulation of granzyme H and granzyme B expression in human lymphocytes. J Biol Chem. 2004;279:26581-26587.
18. Wagner C, Iking-Konert C, Denefleh B, Stegmaier S, Hug F, Hansch GM. Granzyme B and perforin: constitutive expression in human polymorphonuclear neutrophils. Blood. 2004;103:1099-1104.
19. Hochegger K, Eller P, Rosenkranz AR. Granzyme A: an additional weapon of human polymorphonuclear neutrophils (PMNs) in innate immunity? [letter]. Blood. 2004;103:1176.
20. Grossman WJ, Revell PA, Lu ZH, Johnson H, Bredemeyer AJ, Ley TJ. The orphan granzymes of humans andmice. Curr Opin Immunol. 2003;15:544-552.
21. Catalfamo M, Henkart PA. Perforin and the granule exocytosis cytotoxicity pathway. Curr Opin Immunol. 2003;15:522-527.
22. Kagan BL, Ganz T, Lehrer RI. Defensins: a family of antimicrobial and cytotoxic peptides. Toxicology. 1994;87:131-149.
23. Levy O. Antibiotic proteins of polymorphonuclear leukocytes. Eur J Haematol. 1996;56:263-277.
24. van Kessel KP, Verhoef J. A view to a kill: cytotoxic mechanisms of human polymorphonuclear leukocytes compared with monocytes and natural killer cells. Pathobiology. 1990;58:249-264.
25. van Egmond M, van Spriel AB, Vermeulen H, Huls G, van Garderen E, van de Winkel JG. Enhancement of polymorphonuclear cell-mediated tumor cell killing on simultaneous engagement of fcgammaRI (CD64) and fcalphaRI (CD89). Cancer Res. 2001;61:4055-4060.
26. Metkar SS, Froelich CJ. Human neutrophils lack granzyme A, granzyme B, and perforin [letter]. Blood. 2004;104:905-906; author reply 907-908.
27. Grossman WJ, Ley TJ. Granzymes A and B are not expressed in human neutrophils [letter]. Blood. 2004;104:906-907; author reply 907-908.
28. Ebnet K, Chluba-de Tapia J, Hurtenbach U, Kramer MD, Simon MM. In vivo primed mouse T cells selectively express T cell-specific serine proteinase-1 and the proteinase-like molecules granzyme B and C. Int Immunol. 1991;3:9-19.
29. Pardo J, Balkow S, Anel A, Simon MM. The differential contribution of granzyme A and granzyme B in cytotoxic T lymphocyte-mediated apoptosis is determined by the quality of target cells. Eur J Immunol. 2002;32:1980-1985.
30. Ebnet K, Hausmann M, Lehmann-Grube F, et al. Granzyme A-deficient mice retain potent cellmediated cytotoxicity. EMBO J. 1995;14:4230-4239.
31. Rode M, Balkow S, Sobek V, et al. Perforin and Fas act together in the induction of apoptosis, and both are critical in the clearance of lymphocytic choriomeningitis virus infection. J Virol. 2004;78:12395-12405.
32. Calafat J, Janssen H, Stahle-Backdahl M, Zuurbier AE, Knol EF, Egesten A. Human monocytes and neutrophils store transforming growth factor-α in a subpopulation of cytoplasmic granules. Blood. 1997;90:1255-1266.
33. Liou W, Geuze HJ, Slot JW. Improving structural integrity of cryosections for immunogold labeling. Histochem Cell Biol. 1996;106:41-58.
34. Slot JW, Geuze HJ, Gigengack S, Lienhard GE, James DE. Immuno-localization of the insulin regulatable glucose transporter in brown adipose tissue of the rat. J Cell Biol. 1991;113:123-135.
35. Simon MM, Hoschutzky H, Fruth U, Simon HG, Kramer MD. Purification and characterization of a T cell specific serine proteinase (TSP-1) from cloned cytolytic T lymphocytes. EMBO J. 1986;5:3267-3274.
36. Hestdal K, Ruscetti FW, Ihle JN, et al. Characterization and regulation of RB6-8C5 antigen expression on murine bone marrow cells. J Immunol. 1991;147:22-28.
37. Lagasse E, Weissman IL. Flow cytometric identification of murine neutrophils and monocytes. J Immunol Methods. 1996;197:139-150.
38. Kaech SM, Tan JT, Wherry EJ, Konieczny BT, Surh CD, Ahmed R. Selective expression of the interleukin 7 receptor identifies effector CD8 T cells that give rise to long-lived memory cells. Nat Immunol. 2003;4:1191-1198.
39. Baggiolini M, Schnyder J, Bretz U, Dewald B, Ruch W. Cellular mechanisms of proteinase release from inflammatory cells and the degradation of extracellular proteins. Ciba Found Symp. 1979:105-121.